Experimental virus therapy tested as last hope for advanced cancer patients
NCT ID NCT06380309
Summary
This early-stage study is testing the safety and initial effects of a new treatment called IDOV-SAFE in patients with advanced digestive system cancers (like colon, stomach, or liver cancer) who have no other treatment options left. The treatment involves injecting a modified virus into the bloodstream, with the goal of helping the immune system fight the cancer. Researchers will carefully test different doses and combinations with other cancer drugs to find the safest approach.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT SOLID TUMOR OF DIGESTIVE SYSTEM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Cancer Hospital
RECRUITINGBeijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.